abstract |
Encompassed are methods of potentiating anti-tumor immunity comprising administering an RAR agonist to a patient having a tumor in combination with at least one other treatment and methods of suppressing a Th17 response in a patient comprising administering an RAR agonist in combination with at least one other treatment. |